← 返回

淋巴结转移推动全身性疾病

英文原题:Lymph node metastasis fuels systemic disease.

查看英文原题

Lymph node metastasis fuels systemic disease.

PubMed 2022/06/15(内容时间) Trends Cancer Q1 · IF 21.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

淋巴结(LN)转移对全身肿瘤进展的功能影响数十年来一直是一个有争议的问题。在他们最近发表于 Cell 的论文中,Reticker-Flynn 等人证明,对自然杀伤(NK)细胞控制的序贯逃逸和干扰素(IFN)依赖性表观遗传适应增强了 LN 转移的概率。此外,他们表明,一旦形成,LN 转移会扩大全身外周耐受并促进远处器官转移。

展开英文摘要原文

The functional impact of lymph node (LN) metastasis on systemic tumor progression has been a controversial question for decades. In their recent paper published in Cell, Reticker-Flynn et al. demonstrate that sequential evasion of natural killer (NK) cell control and interferon (IFN)-dependent epigenetic adaptation enhances the probability of LN metastasis.

Further, they show that, once formed, LN metastases expand systemic peripheral tolerance and promote distant organ metastasis.

论文信息

作者
Ventre KS、Karakousi T、Lund AW
第一作者单位
Ronald O. Perelman Department of Dermatology, New York University (NYU) Grossman School of Medicine, New York, NY, USA.United States
通讯作者单位
Ronald O. Perelman Department of Dermatology, New York University (NYU) Grossman School of Medicine, New York, NY, USA; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: amanda.lund@nyulangone.org.United States
文献类型
美国 NIH 资助研究 · 非美国政府资助研究 · 评论
期刊
Trends in cancer2022 Aug
原文标识
PubMed 35717536 · DOI 10.1016/j.trecan.2022.06.003